- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04627857
Effect of the Use of Specific Oral Hygiene Devices on Gingival Health Among Patients With Systemic Sclerosis (ScleroBross)
Systemic sclerosis is a rare multisystem connective-tissue disorder characterized by three major pathological hallmarks: widespread fibrosis, vasculopathy and immunological abnormalities. This condition has multiple effects on the orofacial region that is involved in approximately 80% of the patients with a significant impact on the quality of life.
The aim of this randomized single-blind study is to evaluate the impact of the use of a specific oral hygiene instrumentation (sonic toothbrush and water flosser with a large handle) compared to "standard" toothbrushing with a manual toothbrush on the gingival health among patients with systemic sclerosis.
Study Overview
Status
Conditions
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Sophie JUNG
- Phone Number: 00333.88.11.69.56
- Email: sophie.jung1@chru-strasbourg.fr
Study Locations
-
-
-
Strasbourg, France
- Recruiting
- Service de parodontologie
-
Contact:
- Sophie JUNG
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Adult male or female ≥ 18 years (18th birthday completed)
- Affiliation to a social welfare system
- Signed informed consent form
- More than 12 natural teeth suitable for evaluation
- Systemic sclerosis with cutaneous involvement with a diagnosis based on American College of Rheumatology (ACR) and LeRoy and Metzger criteria
Exclusion Criteria:
- Localized scleroderma or systemic sclerosis without cutaneous involvement ("sine scleroderma" limited form)
- Less than 12 natural teeth suitable for evaluation and/or mandibular/maxillary complete denture(s)
- Other progressive chronic illness /autoimmune disease other than systemic sclerosis (e.g. diabetes)
- Another cause of mucocutaneous sclerosis (e.g. radiotherapy involving the oro-facial region)
- Current use of sonic toothbrush and/or dental water flosser
- Severe manual handicap preventing the patient from holding a toothbrush with a large handle
- Oral antiseptics (e.g. chlorhexidin mouthwashes)
- Ongoing medical treatment inducing a significant modification of the gingival state (e.g. anti-epileptic drugs)
- Smoking (≥ 10 cigarettes per day)
- Impossibility to provide accurate information (e.g. emergency situation, comprehension difficulties)
- Individual under guardianship, curatorship or judicial protection
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Arm 1: Manual toothbrush
|
Patients in group 1 (''reference procedure'') receive a manual toothbrush with a small compact head to facilitate access to the posterior teeth and soft bristles.
|
Experimental: Arm 2: Manual toothbrush and water flosser (Philips Sonicare AirFloss Ultra)
|
- Group 2 patients receive a manual toothbrush with a small, compact head for easy access to the posterior teeth and soft bristles.
They also receive a Philips brand interdental microjet (Philips Sonicare AirFloss Ultra) which must be filled with water.
|
Experimental: Arm 3: Manual toothbrush and water flosser (Philips Sonicare AirFloss Ultra)
|
- Group 3 patients receive a rechargeable sonic electric toothbrush from Philipps with an integrated excess pressure sensor and a compact toothbrush head for easy access to the posterior teeth.
|
Experimental: Arm 4: Sonic toothbrush (Philips Sonicare ProtectiveClean) and water flosser
|
- Group 4 patients receive a Philips Sonicare ProtectiveClean rechargeable sonic electric toothbrush with an integrated excess pressure sensor and 2 compact toothbrush heads for easy access to the posterior teeth.
They also receive an interdental microjet from Philips (Philips Sonicare AirFloss Ultra) which must be filled with water.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Changing of plaque index between baseline, week 2 and week 4
Time Frame: day 0, week 2 and week 4
|
day 0, week 2 and week 4
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 8014 (NCI/CTEP)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Scleroderma Systemic
-
Northwestern UniversityCompletedSYSTEMIC SCLERODERMAUnited States
-
Assistance Publique - Hôpitaux de ParisCompletedSYSTEMIC SCLERODERMA | ALLOGENEIC MESENCHYMAL STEM CELLS | ADULTFrance
-
BiocadRecruitingSystemic SclerodermaRussian Federation
-
Rennes University HospitalCompleted
-
Boston UniversityRegeneron PharmaceuticalsCompletedSystemic Sclerosis | Scleroderma | Diffuse Systemic Sclerosis | Diffuse SclerodermaUnited States
-
University Hospital, LilleRecruiting
-
W. Leroy GriffingRecruitingSystemic Sclerosis | Scleroderma, Systemic | Scleroderma, Diffuse | Diffuse Cutaneous Systemic Sclerosis | Interstitial Lung Disease | Scleroderma | Systemic Sclerosis, Diffuse | Diffuse Systemic Sclerosis | Pulmonary Fibrosis Interstitial | Diffuse Scleroderma | Diffuse Cutaneous Scleroderma | Progressive Systemic... and other conditionsUnited States
-
Assistance Publique Hopitaux De MarseilleUnknown
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingSystemic SclerodermaUnited States
-
Fred Hutchinson Cancer CenterNational Institute of Allergy and Infectious Diseases (NIAID)CompletedSystemic Scleroderma | Severe Systemic SclerosisUnited States
Clinical Trials on Manual toothbrush
-
Azienda Socio Sanitaria Territoriale degli Spedali...Completed
-
Procter and GambleCompletedGingivitis | Dental PlaqueCanada
-
Marmara UniversityCompletedPlaque, DentalTurkey
-
Pamukkale UniversityCompletedPeriodontal Inflammation | Toothbrushing | Orthodontic TreatmentTurkey
-
Riccardo PolosaRecruitingDental Plaque | Calculus, DentalItaly
-
Church & Dwight Company, Inc.CompletedDental Devices, Home CareUnited States
-
Church & Dwight Company, Inc.Completed
-
Church & Dwight Company, Inc.Completed
-
Dow University of Health SciencesRecruitingCerebral Palsy, MixedPakistan
-
Marmara UniversityRecruitingGingivitis | Oral Hygiene | Plaque, Dental | Dental Plaque | Periodontal IndexesTurkey